165 related articles for article (PubMed ID: 24100594)
1. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
[TBL] [Abstract][Full Text] [Related]
3. Expression of stanniocalcin 1 as a potential biomarker of gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Matsushita D; Yanagita S; Nakajo A; Okumura H; Hokita S; Natsugoe S
Oncology; 2012; 83(3):158-64. PubMed ID: 22889960
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.
Wang YY; Li L; Zhao ZS; Wang HJ
World J Surg Oncol; 2013 Apr; 11():81. PubMed ID: 23548070
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer.
Uenosono Y; Arigami T; Kozono T; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirata M; Arima H; Funasako Y; Kijima Y; Nakajo A; Okumura H; Ishigami S; Hokita S; Ueno S; Natsugoe S
Cancer; 2013 Nov; 119(22):3984-91. PubMed ID: 23963829
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
10. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of high stanniocalcin 2 expression in solid cancers: A meta-analysis.
Hu L; Zha Y; Kong F; Pan Y
Medicine (Baltimore); 2019 Oct; 98(43):e17432. PubMed ID: 31651846
[TBL] [Abstract][Full Text] [Related]
12. Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood.
Kosaka Y; Mimori K; Fukagawa T; Ishikawa K; Etoh T; Katai H; Sano T; Watanabe M; Sasako M; Mori M
Br J Cancer; 2007 Jun; 96(11):1723-8. PubMed ID: 17486129
[TBL] [Abstract][Full Text] [Related]
13. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
14. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
18. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer].
Zhuge YH; Tao HQ; Wang YY
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2765-8. PubMed ID: 22322056
[TBL] [Abstract][Full Text] [Related]
20. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
